Cargando…
Development and validation of a prognostic 9-gene signature for colorectal cancer
INTRODUCTION: Colorectal cancer (CRC) is one of the most prevalent cancers globally with a high mortality rate. Predicting prognosis using disease progression and cancer pathologic stage is insufficient, and a prognostic factor that can accurately evaluate patient prognosis needs to be developed. In...
Autores principales: | Cui, Junpeng, Guo, Fangyu, Yu, Yifan, Ma, Zihuan, Hong, Yuting, Su, Junyan, Ge, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714635/ https://www.ncbi.nlm.nih.gov/pubmed/36465397 http://dx.doi.org/10.3389/fonc.2022.1009698 |
Ejemplares similares
-
Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019) -
Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019) -
Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019) -
Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022) -
Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer
por: Yang, Jinwei, et al.
Publicado: (2023)